IDDI

428 views
408 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
428
On SlideShare
0
From Embeds
0
Number of Embeds
4
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

IDDI

  1. 1. IDDI / Corporate Presentation eClinical and Biostatistical Services
  2. 2. Company History Inc. Inc. Cambridge, MA, USA Houston, TX, USA1991 1996 2001 2004 2006 2010 2010 2011 Operations centered in Belgium SARL, Paris
  3. 3. IDDI , Clinical Data Centre The mission of IDDI is to deliver clinical trial results that are scientifically accurate, validated and reproducible. 3
  4. 4. ExpertiseConsultancy Clinical trial program strategy, protocol design, expert mission with regulatory agenciesRandomization and Drug Supply Management(e)-CRF Design and Data ManagementBiostatistical Services Biostatistical Analyses Meta-analysesBiomarkers QualificationIDMC supportMedical Writing
  5. 5. Web systemseClinical Suite Central Randomization (ID-net™) and Treatment Allocation (ID-supply™) Data Management (EDC) Coding of Medical Terms (ID-code™)Secured sharing of documents and data (TrialControl™)Validation of systemsCustomer support
  6. 6. Global Experience (> 2002)500+ Phase I-IV trials160+ Randomization systems in 100+ countries 50,000+ patients 6,000+ sites350+ Publications400+ Scientific presentations10 Scientific seminars since 20036 Webinars since 2010 6
  7. 7. Client BaseOver the last 5 years IDDI worked with 110+ clients worldwide Currently 75 clients – 180 projects Other (Medical Devices, Nutrition…) 3% Academic Pharmaceutical Group 24% 17% Biotechnology 56% +75% repeat business!
  8. 8. FDA / EMA approvals Involvement in 15 FDA/EMA approvalsand currently working on 30+ studies to be usedin submission dossiers in the US and/or Europe 8
  9. 9. Experience by Sponsor’s Origin (#of trials over the last 5 years) ASIA GERMANY NORWAY/SWEDEN/ UNITED KINGDOM 1% 2% DENMARK 7% 3% USA CANADA 31% 9% SWITZERLAND 11% BELGIUM / FRANCE NETHERLANDS 21% 15% 9
  10. 10. Experience by Phase(#of trials over the last 5 years) Phase IV Multiple Phase 8% 11% Phase I 13% Phase I/II 2%Phase III 36% Phase II 27% Phase II/III 3% 10
  11. 11. Experience by Therapeutic Area (#of trials over the last 5 years) Multiple Gastroenterology Musculoskeletal Endocrine/ 2% 2% 1% Metabolic Diseases Immunology/ 1% Vaccines 2% Dermatology CNS 1% 2% Infectious Diseases 4% Cardio-vascular/ Cardiology 9% Ophthalmology Oncology 13% 63% 11
  12. 12. Why IDDI?
  13. 13. IDDIs Added ValueTeam of talented professionals with extensivescientific depthDedicated staff with virtually no turnoverRobust, flexible and low-cost EDC and IWR solutions20 years in the clinical research businessRecognized expertise in oncologyTrack record of success storiesExtensive regulatory experience with involvement in15 FDA/EMA approvalsWorldwide reputation and scientific visibilityIndependent status 13

×